Entropy Neurodynamics
Entropy Neurodynamics is an Australian biotechnology company focused on developing novel therapies for neurological and psychiatric disorders. They leverage innovative approaches in drug development, aiming to address unmet needs in mental health and improve patient outcomes. The company is listed on the ASX and seeks to create value through its research and development pipeline.
Short position
Entropy Neurodynamics (ASX:ENP) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 6 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. ENP is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Entropy Neurodynamics (ENP) short interest history
ENP Short Interest History
- 30-day change
- 0.00pp
- 90-day change
- 0.00pp
- 1-year change
- —
- All-time high
- 0.00% (November 2025)
- All-time low
- 0.00% (October 2026)
Is ENP heavily shorted?
Not especially: 0.00% short interest is modest by ASX standards, ranking #790 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has ENP's short interest changed recently?
Over the past 30 days Entropy Neurodynamics's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.00% of shares on issue.
What is the highest ENP's short interest has been?
Since 2025, Entropy Neurodynamics's short interest peaked at 0.00% in November 2025 and bottomed at 0.00% in October 2026.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2025. See our methodology.